Back

Prognostic impact of tricuspid regurgitation improvement after transcatheter mitral valve replacement: results from an international multicenter registry

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Combined approaches for combined cardiac diseases? Intervention EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Ina Von Der Heide

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Does the presence of transcatheter aortic valve replacement (TAVR) service impact acute myocardial infarction care? A binational analysis from MINAP and SWEDEHEART between 2015-2019
Doctor N. Weight (Stoke-on-Trent, GB)
Abstract Slides
Presentation thumbnail
Single-session strategy for severe aortic stenosis with coronary disease: a retrospective observational study
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Prognosis and evolution of tricuspid regurgitation in patients undergoing percutaneous mitral repair for severe mitral regurgitation
Doctor Q. de Baynast (Paris, FR)
Abstract Slides
Presentation thumbnail
Feasibility and outcomes of single-guide catheter combined mitral and tricuspid transcatheter edge-to-edge repair
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Systemic atrioventricular valve transcatheter edge-to-edge repair in ccTGA and surgically corrected TGA with complex anatomies: a case series
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides

Access the full session

Session thumbnail
Combined approaches for combined cardiac diseases?

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources